1 / 34

Tema 28. Priones

Tema 28. Priones. Características generales Estructura y ciclo de multiplicación. Patogenia. Inmunidad. Cuadros clínicos. Diagnóstico. Tratamiento. Epidemiología y Profilaxis. (Viroides). Prions and viroids are unconventional infectious agents

tamera
Download Presentation

Tema 28. Priones

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Tema 28. Priones Características generales Estructura y ciclo de multiplicación. Patogenia. Inmunidad. Cuadros clínicos. Diagnóstico. Tratamiento. Epidemiología y Profilaxis. (Viroides)

  2. Prions and viroids are unconventional infectious agents • Prions—infectious proteins that cause a group of diseases of the brain and nervous system called Transmissible Spongiform Encephalopathies (TSEs) • Viroids—small, pathogenic RNAs that cause viruslike diseases in plants

  3. Características Priones • Proteínas modificadas del hospedador que puede transmitir la enfermedad. • Prión: pequeña partícula infecciosa proteica. (PrP stands for “proteinaceous infectious particle”) • Humanos • Kuru • Enfermedad de Creutzfeldt-Jakob (ECJ) • Animales • Encefalopatía espongiforme bovina (vacas locas)

  4. Estructura y ciclo de multiplicación Tertiary Structure of PrPc and PrPres Two Distinct Conformations of the Prion Protein

  5. PRNP gene encodes PrPC • PRNP gene located on chromosome 20 of humans • Codes for a 254 AA protein. • It is unique (no other proteins of similar homology in the database) • PrPC is targeted via a secretory pathway to the cell surface of neurons and other cell types • A glycosylinositol phospholipid anchors it into the membrane.

  6. Biochemical Analysis of the Prion Amino Acid Sequence

  7. Hypothetical Model showing PrPc Involvement in the Secretory Pathway of Cells

  8. Patogenia • Incubation period of TSEs (with the exception of vCJD) is long (20-56 years) • South Fore tribe members still getting Kuru some 39-56 years after the cessation of cannibalism

  9. Patogenia Histological/Brain Changes of TSEs • Infected brains become spongiform (the brain has vacuoles—clear zones, similar to a sponge) • Neuronal loss • Astrocystosis (spread of astrocytes to damaged tissues in the brain) • Amyloid plaques—formation of PrPres threadlike aggregates

  10. Spongiosis Brain tissues showing histopathologic changes found in bovine spongiform encephalopathy.

  11. Diagram of the Major Regions of the Human Brain Affected by the Different TSEs

  12. Brain Changes • Depending upon what region of the brain is affected • e.g. memory is affected when the cerebral cortex is infected • No inflammation or immune defense against prions exists • Natural proteins (body does not recognize as foreign antigens) • Prion proteins are only harmful when they are converted to PrPres

  13. PRIONES Depósitos de proteínas priónicas

  14. Inmunidad • None of the TSEs evoke an immune response • Prions cause a noninflammatory process that results in vacuolation or spongiosis in the gray matter of the brain

  15. CuadrosClínicos Fore Child with Symptoms of Ambulant Stage A Fore child with symptoms of the ambulant stage of Kuru.

  16. Clinical Signs and Symptoms of Variant Creutzfeldt-Jakob Disease (Variant CJD) • 50% of variant CJD patients die before the age of 30 • average age of death is 28 • Patients suffering from classic CJD die at an average of 68 years

  17. Symptoms of Variant CJD • Anxiety • Memory loss • Mood changes • Depression • Neurological signs • Twitching • Spasms (jerky movements) • Posture and gait abnormalities (motor difficulties)

  18. Final Symptoms of Variant CJD • Loss of speech • Stupor • Persistent vegetative state (coma) • Death (14 months after symptoms appear)

  19. Diagnóstico de CJD • Most patients referred to a psychiatrist because of behavioral changes • Definitive diagnosis—prion positive immunostaining of biopsy material from: • Tonsil • Spleen • Lymph nodes • Electroencefalografía—looking for slow or negative brain wave activity • Resonancia magnética—looking for brain lesions • LCR—looking for elevated levels of neuronal, astrocytic and glial proteins • Elevated levels are a consequence of damage to the blood brain barrier

  20. Gold Standard of Diagnosis is Postmortem Examination of Brain Tissues Detection of PrPres by Western blot analysis. Samples of human brain tissues from a diseased individual suspected of variant CJD.

  21. Human Genetics: Codon 129 • 50 known mutations in the PRNP gene • PRNP codon 129 appears to act as a genetic susceptibility factor (codes for methionine or valine at position 129 of the PrPC). • All people suffering from vCJD acquired through consuming prion-contaminated beef products were homozygous methionine at codon 129

  22. Steps Toward Treatment and Vaccination • No drug therapies available. • Treatment is supportive • No vaccine available • PrPC antibodies injected into the brains of mice cause neurotoxicity

  23. Epidemiología y Profilaxis Prions are highly resistant to routine methods of decontamination • Not inactivated by proteases, organic solvents, alkaline cleaners, ultraviolet radiation, ethanol, formaldehyde or extremely high temperatures (e.g. greater than 100 oC; sterilization for one hour at 121 oC in an autoclave does not kill prions)

  24. Typical Decontamination Protocol that Researchers Use: • Tissues, infectious waste, and instruments used in the processing of prion-contaminated samples are decontaminated in: • 1 N NaOH or undiluted fresh household bleach followed by autoclaving at 132 oC for 4.5 hours

  25. ACCIÓN DE LOS AGENTES FÍSICOS Y QUÍMICOS SOBRE PRIONES.

  26. Transmission • Infection • diet, vCJD • Iatrogenic means (e.g. surgery) • Growth hormone injections • Corneal transplants • Inherited • Genetic CJD • Gerstmann-Straussler-Scheinker Disease (GSS) • Fatal Familial Insomnia (FFI) • Sporadic forms • CJD

  27. Transmission

  28. Species Barrier Bovine Spongiform Encephalopathy (BSE) and Variant Creutzfeldt-Jakob Disease (Variant CJD) • Transmissibility among species is easy • Transmission can occur between different species • Origin of BSE unclear • Accepted hypothesis is that BSE came from cattle ingesting scrapie-contaminated bone meal derived from sheep offal fed to young calves

  29. ENCEFALOPATÍAS ESPONGIFORMES TRANSMISIBLES HOMBRE: • Kuru. • Enfermedad de Creutzfeldt-Jacob (ECJ). • Síndrome de Gerstmann-Straussler (ECJ hereditaria). • Síndrome de insomnio familiar fatal. • Nueva variante de la Enfermedad de Creutzfeldt-Jacob (nv ECJ). ANIMALES: • Scrapie. • Encefalopatía espongiforme bovina (Enfermedad de las vacas locas).

  30. nvECJ • Consumo de derivados bovinos con EEB: amígdalas, retina, tejido nervioso. • Homocigotos met en el codón 129. • Diferencias:

  31. SIMILITUDES Transmisibles. Muy pequeños. Filtrables. Dependientes de la célula huésped. Sin capacidad de: Generar energía. Síntesis proteica. DIFERENCIAS No evidencia de partículas virales. Ácidos nucleicos no detectables. Muy resistentes. No inducen reacción inflamatoria/respuesta inmunitaria. ENCEFALOPATÍAS ESPONGIFORMES SUBAGUDASPRIÓN-VIRIÓN

More Related